Sílvia Marcé

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Tyrosine Kinase

Single Molecule

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sílvia Marcé, Aleix Méndez, Blanca Xicoy Cirici, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano-Serrat, Emilia Scalzulli, Mireia Morgades, Alicia Senín, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Eduardo Anguita, Montserrat Cortés, Esther Plensa, Massimo Breccia, J Valentín García-Gutiérrez, Lurdes Zamora, null null
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of clinical medicine 13 (3) (2024)
Sílvia Marcé, Aleix Méndez, Blanca Xicoy Cirici, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano-Serrat, Emilia Scalzulli, Mireia Morgades, Alicia Senín, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Eduardo Anguita, Montserrat Cortés, Esther Plensa, Massimo Breccia, J Valentín García-Gutiérrez, Lurdes Zamora, null null
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of clinical medicine 13 (3) (2024)
Sílvia Marcé, Blanca Xicoy, Olga García, Marta Cabezón, Natalia Estrada, Patricia Vélez, Concepción Boqué, Miguel Sagüés, Anna Angona, Raul Teruel-Montoya, Francisca Ferrer-Marín, Paula Amat, Juan Carlos Carlos Hernández-Boluda, Mariana M Ibarra, Eduardo Anguita, Montserrat Cortés, Andrés Fernández-Ruiz, Sandra Fontanals, Lurdes Zamora, null On Behalf Of The Grupo Español de Leucemia Mieloide Crónica Gelmc
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. Journal of clinical medicine 10 (14) (2021)